Cullen/Frost Bankers’s Oak Street Health, Inc. OSH Stock Holding History

Cullen/Frost Bankers’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-619	Closed	-$23.9K	–	1310
2023 Q1	$23.9K	Hold	619	–	–	﹤0.01%	834
2022 Q4	$13.3K	Hold	619	–	–	﹤0.01%	894
2022 Q3	$15K	Hold	619	–	–	﹤0.01%	893
2022 Q2	$10K	Sell	619 -44	-7%	-$855	﹤0.01%	915
2022 Q1	$18K	Hold	663	–	–	﹤0.01%	897
2021 Q4	$22K	Hold	663	–	–	﹤0.01%	883
2021 Q3	$28K	Buy	+663	New	+$35.6K	﹤0.01%	907

Other funds holding OSH

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Cullen/Frost Bankers's OSH Position: Q2 2023 in Review

Cullen/Frost Bankers sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 619 shares — an estimated $23.9K sold.

Cullen/Frost Bankers first reported a position in OSH in Q3 2021 and held it in 7 quarters. The position peaked at $28K in Q3 2021. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

Cullen/Frost Bankers reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
Cullen/Frost Bankers sold 619 Oak Street Health, Inc. shares in Q2 2023, an estimated $23.9K.
Cullen/Frost Bankers first reported a position in Oak Street Health, Inc. in Q3 2021 and held it in 7 quarters.
Cullen/Frost Bankers's Oak Street Health, Inc. position peaked at $28K in Q3 2021.
3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Cullen/Frost Bankers's 13F filing for Q2 2023, filed 4 Aug 2023.